SCHEMBL10035398

SCHEMBL10035398

CCCCOB(OCCCC)c1cc2ccccc2c2c1sc1ccccc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
HTT P42858 3/20 0.36
KDM4E B2RXH2 2/20 0.36
NPSR1 Q6W5P4 2/20 0.36
HCRTR1 O43613 1/20 0.36
HPGD P15428 1/20 0.36
MAPT P10636 5/20 0.35
CYP1A2 P05177 4/20 0.35
CYP2C19 P33261 2/20 0.35
CYP2C9 P11712 1/20 0.35
L3MBTL1 Q9Y468 4/20 0.34
ATM Q13315 1/20 0.34
NQO1 P15559 1/20 0.33
NQO2 P16083 1/20 0.33
TP53 P04637 1/20 0.33
CNR2 P34972 2/20 0.32
CNR1 P21554 1/20 0.32
ELANE P08246 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10035417 0.96 L3MBTL1 (0.34) ALDH1A1MEN1KMT2AHTTKDM4E
SCHEMBL10035407 0.95 CNR2 (0.33) ALDH1A1MEN1KMT2AHTTKDM4E
SCHEMBL10035397 0.93 L3MBTL1 (0.36) ALDH1A1MEN1KMT2AHTTKDM4E
SCHEMBL10035406 0.87 L3MBTL1 (0.37) ALDH1A1MEN1KMT2AHTTKDM4E
SCHEMBL10035414 0.82 KDM4E (0.37) ALDH1A1MEN1KMT2AHTTKDM4E
SCHEMBL10035415 0.80 ALDH1A1 (0.40) ALDH1A1MEN1KMT2AHTTKDM4E
SCHEMBL14983532 0.77 TDP1 (0.38) ALDH1A1MAPTCYP1A2L3MBTL1CNR2
SCHEMBL10035405 0.77 ALDH1A1 (0.36) ALDH1A1MEN1KMT2AHTTKDM4E
SCHEMBL10035419 0.77 ALDH1A1 (0.36) ALDH1A1MEN1KMT2AHTTKDM4E
SCHEMBL9950434 0.76 MAPT (0.42) ALDH1A1MEN1KMT2AHTTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8674117-B2 Organoboron compound and method for manufacturing the same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-03-18 US disclosed
US-8674117-B2 Organoboron compound and method for manufacturing the same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-03-18 US disclosed
US-20120165550-A1 Organoboron Compound and Method for Manufacturing the Same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-06-28 US disclosed
US-20120165550-A1 Organoboron Compound and Method for Manufacturing the Same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-06-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120165550-A1 Organoboron Compound and Method for Manufacturing the Same CYP2B6, CBR3, CBR1 ALDH1A1 600/4885MEN1 1969/4885KMT2A 4513/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.